Tao Capital
VC Fund
Beijing, China
Tao Capital is an investment firm.
- Total investments:
- 29
- Last investment:
- Lead investor:
- 31%
Last updated:
For AI agents: llms.txt
Industries Tao Capital invests in
Stages Tao Capital invests in
Countries Tao Capital invests in
Investment Focus
Industry
- Health Care 12 (41%)
- Biotechnology 11 (38%)
- Medical 7 (24%)
- Pharmaceutical 7 (24%)
- Biopharma 6 (21%)
Stage
- Series A 12 (41%)
- Series B 7 (24%)
- Seed 4 (14%)
- Series C 4 (14%)
- Angel 1 (3%)
Country
- China 23 (79%)
- United States 3 (10%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
BCI-Sonics
|
BCI-Sonics is an innovative medtech company developing non-invasive brain-computer interface solutions using advanced transcranial focused ultrasound (tFUS) technology. The company builds a next-generation therapeutic platform enabling precise neuromodulation to treat central nervous system disorders. BCI-Sonics develops low-intensity focusedultrasound technology that non-invasively stimulates deep brain regions with high precision. They combine ultrasound engineering and neuroscience to interface safely and effectively with the human brain without surgery. The company is creating an AI ultrasound brain-computer interface platform for therapeutic neuromodulation applications. | $14.8M / Angel / Jun 08, 2026 | |
TOPI Imaging Technology
|
TOPI Imaging Technology is a medical device firm providing OCT retinal diagnostic system and sweep optical biometer. | $57.9M / Venture - Series Unknown / Mar 26, 2026 | |
|
Xianyan Biopharma
|
Xianyan Biopharma is a company that focuses on core technology innovation and new medication development for oligonucleotides, and it has a top-tier R&D staff. | $21.8M / Series A / Mar 20, 2026 | |
Anaerobic Biotechnology
|
Anaerobic Biology is a domestic leader in the study and development of human microorganisms and has been heavily involved in the study and development of human intestine and vaginal flora. | Series A / Jan 26, 2026 | |
|
Ona Regenerative Medicine
|
Ona Regenerative Medicine is a biotechnology developer specializing in chemical products, focusing on creating innovative solutions that support tissue repair, regeneration, and overall biomedical advancement. | Seed / Nov 13, 2025 | |
Hyperway Pharm
|
Hyperway Pharm is a pharmaceutical R&D and production enterprise with R&D as the core driving force. It adheres to the philosophy of “Hai Na Baichuan, Bocai, Changzhi, Good People, and Great Deeds”, and is committed to building a world-leading research and development platform for small molecule innovative drugs and high-end APIs. Researchand development platform for research and development platforms and high-tech barriers. Its core founding team is a special high-end talent in Chengdu, Sichuan Province, and has many Fortune 500 companies such as Bayer, Johnson & Johnson, Sanofi and Merck, as well as “Kingming Kant”. Work experience of domestic well-known pharmaceutical companies such as “Hengrui”, “Yangzijiang”, “Hai Cisco”, “Smart Chemical” and “Bite Pharmaceutical”, with rich experience in international and domestic drug development and management, and led the team. It has successively developed a number of world-class innovative drugs (which have entered clinical trials) and a number of high-end high-end generic drugs | $28.1M / Series B / Oct 22, 2025 | |
|
Huanxin Medical
|
Huanxin Medical is an innovative medical device company that specializes in the research and development of interventional medical devices. | Series B / Aug 14, 2025 | |
Aoda Biotechnology
|
Aoda Biotechnology is a biopharmaceutical company. | $4.2M / Series A / Aug 11, 2025 | |
|
Tianzhuang Nutrition
|
Tianzhuang Nutrition is an innovative modern enterprise dedicated to the research, development, production, and sales of medical nutritional foods. | Series A / Jul 31, 2025 | |
Challenge IM
|
Challenge IM focuses on the development and application of membrane filtration process products in the biopharmaceutical field. | Seed / Oct 10, 2024 | |
| See all 29 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Tao Capital invest in?
Tao Capital invests primarily in Health Care, Biotechnology and Medical startups, most often at Series A and Series B stage. Most of the 29 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Tao Capital last invest?
The most recent investment recorded for Tao Capital closed in Jun 2026. Shizune tracks 29 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
